Objective: To determine the epidemiology and outcome of patients with systemic lupus erythematosus (SLE) that underwent kidney transplantation in Taiwan.Methods: We retrieved data from the National Health Insurance Research Dataset (NHIRD) and included those patients with newly developed end-stage renal disease (ESRD) who were recognized as having underlying SLE between April 1997 and December 2006. Among these patients we analyzed clinical as well as graft outcome in renal transplant recipients and clinical outcome in those not undergoing renal transplantation.Results: 1073 SLE-ESRD patients, including 115 renal transplant recipients, were analyzed. The mean age on receiving renal allograft was 35.5 years, with a female to male ratio of 4.23:1. The 1-year and 4-year survival rates of the allografts (AS) and the recipients (RS) were 0.94/0.88 (AS) and 0.96/0.93 (RS), respectively. Clinical survival of transplant patients was superior to that of non-transplant patients (hazard ratio = 0.35; 95% CI = 0.14-0.85; p=0.021) after adjusting other major prognosis factors. Factors such as gender, age at transplantation, waiting time for the graft, economic status, pre-transplant renal replacement therapy (RRT) and co-morbidities with hepatitis B (HBV), hepatitis C (HCV), diabetes mellitus (DM) and/or sicca complex had no significant effect on graft success or failure.Conclusion: The clinical and graft survival rates were good in lupus renal transplant recipients in Taiwan. Further in-depth comparison of these features with those of Caucasians or other Asian countries is mandatory to reach a definite conclusion.
- Systemic lupus erythematosus (SLE)
- kidney transplantation
- end-stage renal disease (ESRD)
- clinical survival
- graft survival